Volume: 26S1 - February 2000
Guidelines for Reporting Adverse Events Associated with
Vaccine Products
Supplementary guidelines for the Canadian Pharmaceutical
Industry
Adobe
Downloadable Document
(399 KB)
Table of Contents
I. Introduction
II. General Procedures for Reporting - Features
Unique to Vaccines
References
Appendices
- Common Acronyms
- Summary of Reporting Requirements
- Caveat Statement
- Important Addresses
- Vaccine Associated Adverse Events Reporting
Form
For more information, please contact:
Head, Vaccine Associated Adverse Event Surveillance Section
Division of Immunization
Bureau of Infectious Diseases
Laboratory Centre for Disease Control
(613) 957-1340
[Table of Contents]
[Next]
|